Filing Details
- Accession Number:
- 0001356710-20-000002
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-18 16:24:01
- Reporting Period:
- 2020-12-16
- Accepted Time:
- 2020-12-18 16:24:01
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
109657 | Gt Biopharma Inc. | GTBP | Pharmaceutical Preparations (2834) | 941620407 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1356710 | W Steven Weldon | 401 East Jackson Street Suite 2340 Tampa FL 33602 | No | No | No | Yes |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-12-16 | 50,000 | $0.30 | 4,053,700 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-12-17 | 50,000 | $0.30 | 4,003,700 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-12-17 | 50,000 | $0.31 | 3,953,700 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-12-18 | 50,000 | $0.30 | 3,903,700 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- . The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2020.